JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NETER, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by NETER, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 74, Issue 1, 52-60, 1942
Copyright © 1942 by American Society for Pharmacology and Experimental Therapeutics


AN IN VITRO STUDY ON THE SYNERGISTIC ACTION OF SULFAMIDO COMPOUNDS AND AZOCHLORAMID UPON VARIOUS PATHOGENIC MICROORGANISMS

ERWIN NETER 1

1 From the Laboratories of the Children's Hospital and the Department of Pathology and Bacteriology, University of Buffalo, School of Medicine, Buffalo, New York

An in vitro study on the combined antibacterial activity of sulfamido compounds and azochloramid revealed the following:

1. Azochloramid used in combination with suffanilamide, suffathiazol, and and sulfadiazine may exert greater bacteriostatic activity toward Group A hemolytic streptococcus than does either compound alone in like or somewhat higher concentrations.

2. A slight increase in bacteriostatic activity toward Group D hemolytic streptococcus was obtained when azochloramid was used in conjunction with sulfanilamide.

3. The combined use of azochloramid and sulfanilamide, sulfapyridine, sulfathiazol or sulfadiazine resulted in greater inhibition of growth of penumococcus type I than did that of either drug alone in like or somewhat higher concentrations.

4. The combined use of sulfathiazol or sulfadiazine and azochloramid retarded the growth of staphylococcus aureus hemolyticus to a greater extent than did either drug in like or higher concentrations.

Submitted on September 26, 1941




This article has been cited by other articles:


Home page
Arch SurgHome page
O. C. BRANTIGAN
RESECTION OF THE LUNG IN THE TREATMENT OF PULMONARY TUBERCULOSIS
Arch Surg, October 1, 1945; 51(3): 147 - 153.
[Abstract] [PDF]


Home page
ScienceHome page
THE PERSONNEL OF NAVAL LABORATORY RESEARCH UNIT NO
ATTEMPTS TO PROTECT AGAINST INFLUENZA VIRUS WITH VARIOUS SULFONAMIDES, ACRIDINES AND ANTIBIOTICS
Science, October 15, 1943; 98(2546): 348 - 349.
[PDF]


Home page
Arch OphthalmolHome page
J. G. BELLOWS
CHEMOTHERAPY IN OPHTHALMOLOGY
Arch Ophthalmol, June 1, 1943; 29(6): 888 - 903.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1942 by the American Society for Pharmacology and Experimental Therapeutics.